Last updated on August 2018

Unilateral Meniere's Disease

Brief description of study

A prospective, randomized, double blind, placebo-controlled, multi-center, phase 3 efficacy and safety study of OTO-104 given as a single intratympanic injection in subjects with unilateral Meniere's disease.


Clinical Study Identifier: TX210450

Find a site near you

Start Over

Piedmont Ear, Nose, and Throat Associates

110 Charlois Blvd Winston-Salem, NC USA
  Connect »